Lifshitz & Miller LLP Announces Investigation of Aratana Therapeutics, Inc., FXCM Inc., Innocoll Holdings plc, Momenta Pharmaceuticals, Inc., Omnicom Group Inc., Perrigo Company plc, Santander...

NEW YORK, March 24, 2017 /PRNewswire/ --

Aratana Therapeutics, Inc. (PETX)

Lifshitz & Miller announces investigation on behalf of PETX investors concerning PETX's statements about the commercial viability of ENTYCE.

If you are a PETX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

FXCM Inc. (FXCM)

Lifshitz & Miller announces investigation on behalf of FXCM investors concerning whether FXCM's subsidiary concealed information from its retail foreign exchange customers and issued misleading statements to the national futures association.

If you are an FXCM investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Innocoll Holdings plc (INNL)

Lifshitz & Miller announces investigation on behalf of INNL investors concerning whether INNL's new drug application for its lead drug, XARACOLL, would be completed by 2017 as represented to investors.

If you are an INNL investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Momenta Pharmaceuticals, Inc. (MNTA)

Lifshitz & Miller announces investigation on behalf of MNTA investors concerning the warning letter MNTA received from the FDA regarding approval of MNTA's Glatopa 40mg product.

If you are an MNTA investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Omnicom Group Inc. (OMC)

Lifshitz & Miller announces investigation on behalf of OMC investors concerning whether OMC engaged in illegal price-fixing in video-advertising production.

If you are an OMC investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Perrigo Company plc (PRGO)

Lifshitz & Miller announces investigation on behalf of PRGO investors concerning whether PRGO engaged in price-fixing with generic drug manufacturers to treat skin disorders.

If you are a PRGO investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Santander Consumer USA Holdings Inc. (SC)

Lifshitz & Miller announces investigation on behalf of SC investors concerning SC's financial restatement and whether SC violated generally accepted accounting principles.

If you are a SC investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

The Interpublic Group of Companies, Inc. (IPG)

Lifshitz & Miller announces investigation on behalf of IPG investors concerning whether IPG engaged in an illegal price-fixing scheme with other video-advertising producers.

If you are an IPG investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING. © 2017 Lifshitz & Miller LLP.  The law firm responsible for this advertisement is Lifshitz & Miller LLP, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller LLP
Phone:  516-493-9780 
Facsimile: 516-280-7376
Email: info@jlclasslaw.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lifshitz--miller-llp-announces-investigation-of-aratana-therapeutics-inc-fxcm-inc-innocoll-holdings-plc-momenta-pharmaceuticals-inc-omnicom-group-inc-perrigo-company-plc-santander-consumer-usa-holdings-inc-and-the-in-300429239.html

SOURCE Lifshitz & Miller Law Firm